Vernalis

molecule
MedTech

HitGen picks up Vernalis' drug hunters from Ligand for $25M

Ligand Pharmaceuticals is trading its Vernalis research operations over to Chinese drug discovery biotech HitGen for $25 million in cash.
Conor Hale Oct 12, 2020 10:59am
Close-up of handshake between person in suit and person in business shirt

Vernalis, weakened by FDA rejections, accepts £33M Ligand bid 

Aug 10, 2018 6:09am
Research

Vernalis, Daiichi form oncology drug discovery collaboration

Dec 13, 2017 6:41am
fda

Back-to-back FDA rejections leave Vernalis reeling

Aug 7, 2017 7:49am
London Stock Exchange

Vernalis falls after FDA knocks back cough-cold drug filing

Apr 21, 2017 6:09am
Newspapers

EuroBiotech—More​​​ ​​​Articles​​​ ​​​of​​​ ​​​Note

Mar 9, 2017 9:42am